Intelligent bio solutions inc. announces reverse stock split

New york, jan. 25, 2024 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“intelligent bio solutions” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced that it will effect a 1-for-12 reverse split of its common stock, that will become effective at 5:00 pm (eastern time) on january 26, 2024. trading of the company's common stock on the nasdaq capital market (“nasdaq”) will continue, on a split-adjusted basis, with the opening of the markets on january 29, 2024, under the trading symbol “inbs” and new cusip number 36151g600.
INBS Ratings Summary
INBS Quant Ranking